First Report Customer Care 
All time: 4.6

Latest / Last 30 Days: 5.0

527 Reviews

Credit Rating - UK CELL THERAPY GROUP LIMITED

ANALYSIS
Credit Risk Update: UK CELL THERAPY GROUP LIMITED, MAGDALEN CENTRE, ROBERT ROBINSON AVENUE, OXFORD, OX4 4GA. The legal status is a Private Limited Company and the current status at the registry of companies is Active. The company was incorporated on 17 February 2024.

The accounts next due date is 17 November 2025. There are no mortgages.

The above was based on public record information as at 10 November 2024 and may not reflect the current status. Please access the current report to ascertain the current status and credit rating.
SUMMARY
Registered Number: 15497965
Date Incorporated: 17 February 2024
Date Latest Accounts: Unknown
BUSINESS INFORMATION
Legal Form: Private Limited Company
Previous Names: None
Registered Number: 15497965
Annual Return: Unknown
Registered Office: MAGDALEN CENTRE, ROBERT ROBINSON AVENUE, OXFORD, OX4 4GA
SIC Code and Operations: 86220
SECURED CREDITORS
Number of Mortgages 0
Satisfied Mortgages 0
Part Satisfied Mortgages 0
Unsatisfied Mortgages 0
CREDIT RISK RATING
This is the credit risk assessment used by one of the top UK credit reference agencies.
Risk Score (1-100):

UK CELL THERAPY GROUP LIMITED

Click Here

to view this information

Risk Assessment:
Credit Rating:



First Report Score: (0-10):

Financial Status Guide:
10  trafficlight Very Strong
9   Strong
8 Very Good
7 Good
6 Above Average
5 Average
4 Below Average
3 Poor
2 Weak
1 Very Weak
0 Critical
Report Created On 20 November 2024 Copyright © 2024 First Report Ltd


Recent Searches

Reg No. Reg Name Status
SC389832 UK CELLAR COOLING LIMITED Active
06603489 UK CELT' FAIRY JEWELLERY LIMITED Active
10078241 UK CELTIC PETRIFACTION GROUP LIMITED Active - Proposal to Strike off
10383709 UK CELTIC SNACKS GROUP HOLDINGS LTD Active - Proposal to Strike off
11462323 UK CELTIC SNACKS GROUP HOLDINGS LTD Active - Proposal to Strike off

In using this service you agree to the Terms and Conditions

© 2024 First Report Ltd